Pfizer Alters Timeline for Drug Approval Plans Pfizer changes plans for US and European drug approval, initially set for early 2025. Explore the implications of this strategic shift.
Zepbound: First Approved Treatment for Sleep Apnea in Obese Adults Zepbound is now the first FDA-approved medication for treating moderate-to-severe obstructive sleep apnea in adults with obesity, offering new hope for sufferers.